INS and type 1 diabetes mellitus: Another study15 assessed the use of closed-loop insulin delivery during night time in pregnant women with type 1 diabetes, using a control algorithm with a lower glucose setpoint to accommodate lower glucose targets (3·5–7·8 mmol/L) for this group of patients.